Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells

Immunology Letters

Volumn 161, Issue 1, 2014, Pages 76-80

  Yao, Lan ^a   Chen, Hai ping ^a   Ma, Qing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Lupus; MRL Fas(lpr) mice; Piperlongumine; Regulatory T cells; Th17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; JANUS KINASE; PIPERLONGUMINE; PLANT MEDICINAL PRODUCT; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; AUTOANTIBODY; COMPLEMENT COMPONENT C3; CYTOKINE; IMMUNOGLOBULIN G; PIPERLONGUMININE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GLOMERULONEPHRITIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NONHUMAN; PATHOGENESIS; PIPER LONGUM; PRIORITY JOURNAL; PROTEINURIA; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN CELL; TH17 CELL; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; KIDNEY; KIDNEY FUNCTION TEST; LYMPHOCYTE COUNT; METABOLISM; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; COMPLEMENT C3; CYTOKINES; DIOXOLANES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; JANUS KINASES; KIDNEY; KIDNEY FUNCTION TESTS; LUPUS NEPHRITIS; LYMPHOCYTE COUNT; MICE; MICE, INBRED MRL LPR; PROTEINURIA; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84901619105     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.05.001     Document Type: Article

References (25)

1. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Eng J Med 2008, 358:929-939.
2. Lourenço E.V., Wong M., Hahn B.H., Palma-Diaz M.F., Skaggs B.J. Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells. Arthritis Rheumatol 2014, 66:674-685.
3. Kulkarni O.P., Anders H.-J. Lupus nephritis. How latest insights into its pathogenesis promote novel therapies. Curr Opin Rheumatol 2012, 24:457-465.
4. Kumar S1, Kamboj J., Suman Sharma S. Overview for various aspects of the health benefits of Piper longum linn fruit. J Acupunct Meridian Stud 2011, 4:134-140.
5. Jin Z., Borjihan G., Zhao R., Sun Z., Hammond G.B., Uryu T. Antihyperlipidemic compounds from the fruit of Piper longum L. Phytother Res 2009, 23:1194-1196.
6. Park B.S., Son D.J., Choi W.S., Takeoka G.R., Han S.O., Kim T.W., et al. Antiplatelet activities of newly synthesized derivatives of piperlongumine. Phytother Res 2008, 22:1195-1199.
7. Lee W., Yoo H., Kim J.A., Lee S., Jee J.G., Lee M.Y., et al. Barrier protective effects of piperlonguminine in LPS-induced inflammation in vitro and in vivo. Food Chem Toxicol 2013, 58:149-157.
8. Rodrigues Silva D., Baroni S., Svidzinski A.E., Bersani-Amado C.A., Cortez D.A. Anti-inflammatory activity of the extract, fractions and amides from the leaves of Piper ovatum Vahl (Piperaceae). J Ethnopharmacol 2008, 116:569-573.
9. Raj L., Ide T., Gurkar A.U., Foley M., Schenone M., Li X., et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475:231-234.
10. Jiang C., Zhao M.L., Scearce R.M., Diaz M. Activation-induced deaminase- deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum 2011, 63:1086-1096.
11. Yokogawa M., Takaishi M., Nakajima K., Kamijima R., Fujimoto C., Kataoka S., et al. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus. Arthritis Rheumatol 2014, 66:694-706.
12. Fiocco U., Accordi B., Martini V., Oliviero F., Facco M., Cabrelle A., et al. JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis. Immunol Res 2014, 58:61-69.
13. Egwuagu C.E. STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 2009, 47:149-156.
14. Robinson K.M., Manni M.L., Biswas P.S., Alcorn J.F. Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders. Curr Allergy Asthma Rep 2013, 13:587-595.
15. Maddur M.S., Miossec P., Kaveri S.V., Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012, 181:8-18.
16. Murdaca G., Colombo B.M., Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med 2011, 6:487-495.
17. Chen Z., Tato C.M., Muul L., Laurence A., O'Shea J.J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007, 56:2936-2946.
18. Wang Q.Q., Yang H.Z., Liu H.Z., Mi S., Zhang X.W., Yan H.M., et al. Interleukin-17A is involved in development of spontaneous pulmonary emphysema caused by Toll-like receptor 4 mutation. Acta Pharmacol Sin 2011, 32:1045-1054.
19. Chen D.Y., Chen Y.M., Wen M.C., Hsieh T.Y., Hung W.T., Lan J.L. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 2012, 21:1385-1396.
20. Kim S.J., Chen Z., Chamberlain N.D., Volin M.V., Swedler W., Volkov S., et al. Angiogenesis in rheumatoid arthritis is fostered directly by toll-like receptor 5 ligation and indirectly through interleukin-17 induction. Arthritis Rheum 2013, 65:2024-2036.
21. Pisitkun P., Ha H.L., Wang H., Claudio E., Tivy C.C., Zhou H., et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 2012, 37:1104-1115.
22. Wang P., Zheng S.G. Regulatory T cells and B cells, implication on autoimmune diseases. Int J Clin Exp Pathol 2013, 6:2668-2674.
23. Xing Q., Wang B., Su H., Cui J., Li J. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int 2012, 32:949-958.
24. Zubair A., Frieri M. Lupus nephritis: review of the literature. Curr Allergy Asthma Rep 2013, 13:580-586.
25. Yap D.Y., Lai K.N. The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside. Nephrology (Carlton) 2013, 18:243-255.